The Winship Cancer Institute of Emory University

Atlanta, Georgia 30322-1013

2 studies enrolling now · 5 studies all time

What they study most

Low Grade Upper Tract Urothelial Carcinoma, Multiple Myeloma, Myeloma, Myeloma Multiple, Neoplasms, Prostatic Neoplasms, Castration-Resistant, Tenosynovial Giant Cell Tumor

Studies at this site

• Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma — Recruiting now
• A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma — Recruiting now
• A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor — Recruiting now
• A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma — Running, not enrolling
• A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate Cancer — Stopped early